Last reviewed · How we verify
Viscoat
At a glance
| Generic name | Viscoat |
|---|---|
| Sponsor | Innovative Medical |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Evaluation of a New Viscoelastic for Cataract Surgery (NA)
- Endothelial Side Up Inverted Femtosecond Laser Assisted DSAEK (NA)
- Efficacy of Formulated Posterior Sub Tenon Triamcinolone in Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusions (NA)
- Bausch & Lomb Ophthalmic Viscosurgical Device (OVD) Dispersive (DVisc40) (NA)
- Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings (NA)
- Treatment of Malignant Glaucoma by Anterior Vitrectomy From Two Different Approaches
- Viscoat Versus Visthesia. A Comparative Study of Post-cataract Endothelial Cell Loss (NA)
- Intraoperative and Postoperative Outcomes of Three Ophthalmic Viscosurgical Devices During Phacoemulsification (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Viscoat CI brief — competitive landscape report
- Viscoat updates RSS · CI watch RSS
- Innovative Medical portfolio CI